


Intel shareholders approve equity incentive plan, new CEO pay
SAN FRANCISCO (Reuters) -Intel shareholders on Tuesday approved a measure by the chipmaker aimed at topping up share reserves to attract and retain new employees, and compensation for its new CEO Lip-Bu Tan.Intel shares fell 1.6% in early afternoon trading after...
Cisco shows quantum networking chip, opens new lab
By Stephen NellisSAN FRANCISCO (Reuters) -Cisco Systems on Tuesday showed a prototype chip for networking quantum computers together and said it is opening a new lab in Santa Monica, California, to further pursue quantum computing.The chip uses some of the same...
Stressed US companies restructured more debt in April
By Shankar Ramakrishnan(Reuters) -Debt restructuring by financially stressed U.S. companies rose nearly 60% in April, data from JPMorgan showed on Tuesday, as businesses faced pressure from rising tariffs, inflation and capital markets volatility.These operations are...
Buffett’s Dairy Queen on guard as tariffs weigh on desire to dine out
By Jonathan StempelOMAHA, Nebraska (Reuters) -Dairy Queen, owned by Warren Buffett’s Berkshire Hathaway, has seen signs that consumers are dining out less, but believes American franchisees can withstand economic pressures, including from tariffs, its chief...
US will not pay for California high-speed rail, Trump says
By David Shepardson and Steve HollandWASHINGTON (Reuters) – The U.S. government will not pay for a high-speed rail line planned between Los Angeles and San Francisco, President Donald Trump told reporters at the White House on Tuesday, citing cost overruns.The...
SpaceX gets FAA approval to ramp up Starship launches from Texas
By Joey RouletteWASHINGTON (Reuters) -SpaceX received key U.S. regulatory approval on Tuesday to increase the annual rate of Starship rocket launches from Texas and booster landings in various bodies of water, allowing Elon Musk’s space company to significantly...
Pharma imports to US surged in March as drugmakers look to avoid tariffs
By Michael ErmanNEW YORK (Reuters) -Pharmaceutical imports to the U.S. surged in March as drugmakers stocked up ahead of potential U.S. tariffs on their products, which have historically been exempt from such fees.Total imports of pharmaceutical products exceeded $50...